Trial Profile
Efficacy and use of Elbasvir/grazoprevir in post-liver transplant patients re-infected with Hepatitis C Virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Asunaprevir/daclatasvir; Ledipasvir/sofosbuvir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 06 Dec 2018 New trial record
- 01 Nov 2018 Results published in the Hepatology Research